Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu Lou

Showing results (141-150 of 233) with videos related to

Pageof 24
Sort By:
Antimicrobial Agents and Chemotherapy|March 30, 2006
Ritonavir increases plasma amprenavir (APV) exposure to a similar extent when coadministered with either fosamprenavir or APVMary B Wire, Katherine L Baker, Lori S Jones, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2007
Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchangedMary B Wire, Charles H Ballow, Julie Borland, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice dailyGeoffrey J Yuen, Yu Lou, Nancy F Bumgarner, et al.
Journal of Hazardous Materials|September 8, 2021
Response of the yellow mealworm (Tenebrio molitor) gut microbiome to diet shifts during polystyrene and polyethylene biodegradationYu Lou, Yiran Li, Baiyun Lu, et al.
Journal of Food Science|January 16, 2025
Flaxseed gum nano-microcapsules loaded with secoisolariciresinol diglucoside: Preparation and characterizationXu Fang, Yu Lou, Kun He, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2006
Coadministration of esomeprazole with fosamprenavir has no impact on steady-state plasma amprenavir pharmacokineticsMark J Shelton, Susan L Ford, Julie Borland, et al.
British Journal of Clinical Pharmacology|January 15, 2017
Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult womenChristine Trezza, Susan L Ford, Elizabeth Gould, et al.
International Journal of Clinical and Experimental Medicine|July 30, 2015
Snail promotes epithelial-mesenchymal transition and invasiveness in human ovarian cancer cellsYu-Lou Wang, Xue-Min Zhao, Zhi-Feng Shuai, et al.
The Journal of Antimicrobial Chemotherapy|April 16, 2011
Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteersParul Patel, Ivy Song, Julie Borland, et al.
Pancreas|January 18, 2022
Identification of 2 Chinese Primary Pancreatic Ductal Adenocarcinoma Cancer Cell Lines and Their PhenotypesJianxin Wang, Enliang Li, Qi Chen, et al.
Pageof 24

Showing results (141-150 of 233) with videos related to

Sort By:
Pageof 24
Antimicrobial Agents and Chemotherapy|March 30, 2006
Ritonavir increases plasma amprenavir (APV) exposure to a similar extent when coadministered with either fosamprenavir or APVMary B Wire, Katherine L Baker, Lori S Jones, et al.
Antimicrobial Agents and Chemotherapy|May 23, 2007
Fosamprenavir plus ritonavir increases plasma ketoconazole and ritonavir exposure, while amprenavir exposure remains unchangedMary B Wire, Charles H Ballow, Julie Borland, et al.
Antimicrobial Agents and Chemotherapy|December 25, 2003
Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice dailyGeoffrey J Yuen, Yu Lou, Nancy F Bumgarner, et al.
Journal of Hazardous Materials|September 8, 2021
Response of the yellow mealworm (Tenebrio molitor) gut microbiome to diet shifts during polystyrene and polyethylene biodegradationYu Lou, Yiran Li, Baiyun Lu, et al.
Journal of Food Science|January 16, 2025
Flaxseed gum nano-microcapsules loaded with secoisolariciresinol diglucoside: Preparation and characterizationXu Fang, Yu Lou, Kun He, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 28, 2006
Coadministration of esomeprazole with fosamprenavir has no impact on steady-state plasma amprenavir pharmacokineticsMark J Shelton, Susan L Ford, Julie Borland, et al.
British Journal of Clinical Pharmacology|January 15, 2017
Lack of effect of oral cabotegravir on the pharmacokinetics of a levonorgestrel/ethinyl oestradiol-containing oral contraceptive in healthy adult womenChristine Trezza, Susan L Ford, Elizabeth Gould, et al.
International Journal of Clinical and Experimental Medicine|July 30, 2015
Snail promotes epithelial-mesenchymal transition and invasiveness in human ovarian cancer cellsYu-Lou Wang, Xue-Min Zhao, Zhi-Feng Shuai, et al.
The Journal of Antimicrobial Chemotherapy|April 16, 2011
Pharmacokinetics of the HIV integrase inhibitor S/GSK1349572 co-administered with acid-reducing agents and multivitamins in healthy volunteersParul Patel, Ivy Song, Julie Borland, et al.
Pancreas|January 18, 2022
Identification of 2 Chinese Primary Pancreatic Ductal Adenocarcinoma Cancer Cell Lines and Their PhenotypesJianxin Wang, Enliang Li, Qi Chen, et al.
Pageof 24